Product
APB-R3
1 clinical trial
2 indications
Indication
Still's DiseaseIndication
Adult-OnsetClinical trial
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Dose of APB-R3 in Healthy ParticipantsStatus: Completed, Estimated PCD: 2023-12-19